Literature DB >> 19771403

[Does dilution have an impact on cosmetic results with BoNT/A? Complex-protein-free BoNT/A for treatment of glabella lines].

W Prager1, I Zschocke, C Reich, L Brocatti, K Henning, V Steinkraus.   

Abstract

BACKGROUND: In this 2-armed, randomized study we investigated the efficacy and tolerability of complex-protein-free botulinum neurotoxin type A (BoNT/A), applied in two different dilution volumes for treatment of glabellar lines. PATIENTS AND METHODS: 40 patients with grade 2-3 glabellar lines (Facial Wrinkle Scale) received treatment with 25U BoNT/A (Xeomin). 100U of botulinum neurotoxin were diluted in 2.5 ml (group I) or 4 ml sodium chloride solution (group II). Responders showed an improvement in the wrinkle score (independent rater) of at least one point. RESULTS. Response rates two weeks after treatment were 100% / 89.5%, at 3 months 84.2% / 64.7% and at 4 months 53.3% / 61.5% (groups I / II respectively). There was no significant difference between the two dilutions.
CONCLUSION: Complex-protein-free botulinum neurotoxin type A in both dilutions effectively reduced severity of glabellar lines. There was no statistically significant difference in efficacy between the two dilutions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19771403     DOI: 10.1007/s00105-009-1840-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  20 in total

Review 1.  Clinical presentation and management of antibody-induced failure of botulinum toxin therapy.

Authors:  Dirk Dressler
Journal:  Mov Disord       Date:  2004-03       Impact factor: 10.338

2.  Effect of volume and concentration on the diffusion of botulinum exotoxin A.

Authors:  T S Jeffrey Hsu; Jeffrey S Dover; Kenneth A Arndt
Journal:  Arch Dermatol       Date:  2004-11

3.  A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.

Authors:  R Benecke; W H Jost; P Kanovsky; E Ruzicka; G Comes; S Grafe
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

Review 4.  [Consensus recommendations on the use of botulinum toxin type A in aesthetic medicine].

Authors:  Boris Sommer; Dorothee Bergfeld; Gerhard Sattler
Journal:  J Dtsch Dermatol Ges       Date:  2007-02       Impact factor: 5.584

5.  Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?

Authors:  Alastair Carruthers; Jean Carruthers; Joel Cohen
Journal:  Dermatol Surg       Date:  2007-01       Impact factor: 3.398

Review 6.  Dilution and storage of botulinum toxin.

Authors:  A W Klein
Journal:  Dermatol Surg       Date:  1998-11       Impact factor: 3.398

7.  Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences.

Authors:  H Göschel; K Wohlfarth; J Frevert; R Dengler; H Bigalke
Journal:  Exp Neurol       Date:  1997-09       Impact factor: 5.330

Review 8.  Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia.

Authors:  Wolfgang H Jost; Jörg Blümel; Susanne Grafe
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines.

Authors:  Jean D Carruthers; Nicolas J Lowe; M Alan Menter; John Gibson; Nina Eadie
Journal:  Plast Reconstr Surg       Date:  2003-09-15       Impact factor: 4.730

10.  A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.

Authors:  Benjamin Ascher; Benjamin Zakine; Philippe Kestemont; Martine Baspeyras; Ali Bougara; José Santini
Journal:  J Am Acad Dermatol       Date:  2004-08       Impact factor: 11.527

View more
  5 in total

1.  Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA.

Authors:  Gabriele F Muti; Matteo Basso
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

2.  [Treatment of crow's feet with two different botulinum toxin type A preparations in split-face technique].

Authors:  W Prager; E Wissmüller; B Kollhorst; A Böer; I Zschocke
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

3.  Evaluating the Effect of Incobotulinumtoxin A for Glabellar, Forehead, and Crow's Feet Lines Using A High Dilution.

Authors:  Sheila C Barbarino; Jani A J van Loghem; Cheryl M Burgess; Niamh Corduff
Journal:  J Clin Aesthet Dermatol       Date:  2021-08-01

4.  A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines.

Authors:  Anna Rostedt Punga; Mohammad Alimohammadi; Dan Fagrell; Frida Nyberg; Diane Rees; Cindy Wong
Journal:  Dermatol Surg       Date:  2016-08       Impact factor: 3.398

5.  Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines.

Authors:  Welf Prager
Journal:  Clin Pharmacol       Date:  2013-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.